Cargando…

Clinical observation of allergic contact stomatitis treated with Kangfuxin solution as adjuvant: case report

BACKGROUND: Allergic contact stomatitis (ACS) is common among people with allergic constitution and who have allergy reaction to specific allergen such as drugs, food, and materials because of immune dysfunction. With the development of materials science, the increasing diversity of cosmetics and fo...

Descripción completa

Detalles Bibliográficos
Autores principales: Zang, Xiaoyi, Du, Wenjuan, Geng, Funeng, Meng, Panpan, E, Lingling, Zhang, Haizhong, Wang, Xinling, Li, Lin, Xiao, Rui
Formato: Online Artículo Texto
Lenguaje:English
Publicado: AME Publishing Company 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9279792/
https://www.ncbi.nlm.nih.gov/pubmed/35845480
http://dx.doi.org/10.21037/atm-22-2734
_version_ 1784746480120102912
author Zang, Xiaoyi
Du, Wenjuan
Geng, Funeng
Meng, Panpan
E, Lingling
Zhang, Haizhong
Wang, Xinling
Li, Lin
Xiao, Rui
author_facet Zang, Xiaoyi
Du, Wenjuan
Geng, Funeng
Meng, Panpan
E, Lingling
Zhang, Haizhong
Wang, Xinling
Li, Lin
Xiao, Rui
author_sort Zang, Xiaoyi
collection PubMed
description BACKGROUND: Allergic contact stomatitis (ACS) is common among people with allergic constitution and who have allergy reaction to specific allergen such as drugs, food, and materials because of immune dysfunction. With the development of materials science, the increasing diversity of cosmetics and food additives has gradually raised the incidence rate of ACS. Now systemic and local therapy are adopted in the therapy of ACS. However, the systemic therapy would drop the drugs’ concentration after it reaches the treatment area through the layers of human barriers, while the locally-used drugs such as collutory may not be suitable for patients with skin lesion. Kangfuxin contains a variety of biological extracts which is anti-inflammatory and curative and can produce connective tissues whether it's skin or mucous membrane. It can be used not only in non-oral diseases such as gastric ulcer or gynecological diseases, but also in the treatment of recurrent aphthous ulcer and many kinds of stomatitis and has shown good anti-inflammatory and curative effects. This study aimed to explore the effectiveness of Kangfuxin solution as a local-used adjuvant drug to treat ACS. CASE DESCRIPTION: We present a 22-year-old male with ACS whose complaint at the first visit was severe pain, accompanied by salivation, tongue enlargement, bleeding, tonsil enlargement, and symptoms of difficulty in eating, fatigue, and dizziness. After the physical and laboratory examination, we found no abnormalities other than a history of eating the kiwi fruit, which is a common allergen. Thus, he was diagnosed as ACS. In this case, we provided a pharmacologic therapeutic intervention of chlorpheniramine (one tablet, three times a day) and Kangfuxin solution (gargle for 15 min, three times a day) with advice that no exposure to the allergen. On the third day, the patient felt no significant relief of symptoms, while one week after the first visit, the symptoms had obviously alleviated and most of the red lip erosion disappeared. The patient recovered completely with no discomfort in ten days after the initial visit. CONCLUSIONS: This study investigated the therapeutic effect of Kangfuxin solution combined with chlorpheniramine on ACS.
format Online
Article
Text
id pubmed-9279792
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher AME Publishing Company
record_format MEDLINE/PubMed
spelling pubmed-92797922022-07-15 Clinical observation of allergic contact stomatitis treated with Kangfuxin solution as adjuvant: case report Zang, Xiaoyi Du, Wenjuan Geng, Funeng Meng, Panpan E, Lingling Zhang, Haizhong Wang, Xinling Li, Lin Xiao, Rui Ann Transl Med Case Report BACKGROUND: Allergic contact stomatitis (ACS) is common among people with allergic constitution and who have allergy reaction to specific allergen such as drugs, food, and materials because of immune dysfunction. With the development of materials science, the increasing diversity of cosmetics and food additives has gradually raised the incidence rate of ACS. Now systemic and local therapy are adopted in the therapy of ACS. However, the systemic therapy would drop the drugs’ concentration after it reaches the treatment area through the layers of human barriers, while the locally-used drugs such as collutory may not be suitable for patients with skin lesion. Kangfuxin contains a variety of biological extracts which is anti-inflammatory and curative and can produce connective tissues whether it's skin or mucous membrane. It can be used not only in non-oral diseases such as gastric ulcer or gynecological diseases, but also in the treatment of recurrent aphthous ulcer and many kinds of stomatitis and has shown good anti-inflammatory and curative effects. This study aimed to explore the effectiveness of Kangfuxin solution as a local-used adjuvant drug to treat ACS. CASE DESCRIPTION: We present a 22-year-old male with ACS whose complaint at the first visit was severe pain, accompanied by salivation, tongue enlargement, bleeding, tonsil enlargement, and symptoms of difficulty in eating, fatigue, and dizziness. After the physical and laboratory examination, we found no abnormalities other than a history of eating the kiwi fruit, which is a common allergen. Thus, he was diagnosed as ACS. In this case, we provided a pharmacologic therapeutic intervention of chlorpheniramine (one tablet, three times a day) and Kangfuxin solution (gargle for 15 min, three times a day) with advice that no exposure to the allergen. On the third day, the patient felt no significant relief of symptoms, while one week after the first visit, the symptoms had obviously alleviated and most of the red lip erosion disappeared. The patient recovered completely with no discomfort in ten days after the initial visit. CONCLUSIONS: This study investigated the therapeutic effect of Kangfuxin solution combined with chlorpheniramine on ACS. AME Publishing Company 2022-06 /pmc/articles/PMC9279792/ /pubmed/35845480 http://dx.doi.org/10.21037/atm-22-2734 Text en 2022 Annals of Translational Medicine. All rights reserved. https://creativecommons.org/licenses/by-nc-nd/4.0/Open Access Statement: This is an Open Access article distributed in accordance with the Creative Commons Attribution-NonCommercial-NoDerivs 4.0 International License (CC BY-NC-ND 4.0), which permits the non-commercial replication and distribution of the article with the strict proviso that no changes or edits are made and the original work is properly cited (including links to both the formal publication through the relevant DOI and the license). See: https://creativecommons.org/licenses/by-nc-nd/4.0 (https://creativecommons.org/licenses/by-nc-nd/4.0/) .
spellingShingle Case Report
Zang, Xiaoyi
Du, Wenjuan
Geng, Funeng
Meng, Panpan
E, Lingling
Zhang, Haizhong
Wang, Xinling
Li, Lin
Xiao, Rui
Clinical observation of allergic contact stomatitis treated with Kangfuxin solution as adjuvant: case report
title Clinical observation of allergic contact stomatitis treated with Kangfuxin solution as adjuvant: case report
title_full Clinical observation of allergic contact stomatitis treated with Kangfuxin solution as adjuvant: case report
title_fullStr Clinical observation of allergic contact stomatitis treated with Kangfuxin solution as adjuvant: case report
title_full_unstemmed Clinical observation of allergic contact stomatitis treated with Kangfuxin solution as adjuvant: case report
title_short Clinical observation of allergic contact stomatitis treated with Kangfuxin solution as adjuvant: case report
title_sort clinical observation of allergic contact stomatitis treated with kangfuxin solution as adjuvant: case report
topic Case Report
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9279792/
https://www.ncbi.nlm.nih.gov/pubmed/35845480
http://dx.doi.org/10.21037/atm-22-2734
work_keys_str_mv AT zangxiaoyi clinicalobservationofallergiccontactstomatitistreatedwithkangfuxinsolutionasadjuvantcasereport
AT duwenjuan clinicalobservationofallergiccontactstomatitistreatedwithkangfuxinsolutionasadjuvantcasereport
AT gengfuneng clinicalobservationofallergiccontactstomatitistreatedwithkangfuxinsolutionasadjuvantcasereport
AT mengpanpan clinicalobservationofallergiccontactstomatitistreatedwithkangfuxinsolutionasadjuvantcasereport
AT elingling clinicalobservationofallergiccontactstomatitistreatedwithkangfuxinsolutionasadjuvantcasereport
AT zhanghaizhong clinicalobservationofallergiccontactstomatitistreatedwithkangfuxinsolutionasadjuvantcasereport
AT wangxinling clinicalobservationofallergiccontactstomatitistreatedwithkangfuxinsolutionasadjuvantcasereport
AT lilin clinicalobservationofallergiccontactstomatitistreatedwithkangfuxinsolutionasadjuvantcasereport
AT xiaorui clinicalobservationofallergiccontactstomatitistreatedwithkangfuxinsolutionasadjuvantcasereport